Companies › PMN

PROMIS NEUROSCIENCES INC (PMN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001374339 · EDGAR filings · Updated 2026-07-28

PROMIS NEUROSCIENCES INC (PMN) has reported institutional ownership of 68.5%, with 25 institutional managers holding positions valued at $78.0M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-05-29 — Employee-plan registration (S-8) filed
• 2026-05-22 — Insider transaction reported (Form 4)
• 2026-05-22 — Insider transaction reported (Form 4)
• 2026-05-22 — Insider transaction reported (Form 4)
• 2026-05-22 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PROMIS NEUROSCIENCES INC has 25 institutional holders and institutional ownership of 68.5%.

Insider activity

Insiders reported 26 transactions (6 buys, 1 sells) across 15 reporting insiders, with a net reported value of $8.67M.

Data flags from SEC filings

Related companies

ADLAI NORTYE LTD (ANL) · DIAMEDICA THERAPEUTICS INC (DMAC) · STEREOTAXIS INC (STXS) · APYX MEDICAL CORPORATION (APYX) · PROKIDNEY CORP (PROK) · AN2 Therapeutics Inc (ANTX)